Hui Qu

1.7k total citations
36 papers, 1.3k citations indexed

About

Hui Qu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui Qu has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Hui Qu's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hui Qu is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hui Qu collaborates with scholars based in China, United States and Germany. Hui Qu's co-authors include Changgeng Qian, Xiong Cai, Rudi Bao, Cheng-Jung Lai, Ling Yin, Hai-Xiao Zhai, Jeffrey Forrester, Da-Gong Wang, Guang-Xin Xu and Ruzanna Atoyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hui Qu

32 papers receiving 1.3k citations

Peers

Countries citing papers authored by Hui Qu

Since Specialization

Citations

This map shows the geographic impact of Hui Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Qu more than expected).

Fields of papers citing papers by Hui Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Qu. The network helps show where Hui Qu may publish in the future.

Co-authorship network of co-authors of Hui Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Qu. A scholar is included among the top collaborators of Hui Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Qu. Hui Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Replication factor C4, which is regulated by insulin-like growth factor 2 mRNA binding protein 2, enhances the radioresistance of breast cancer by promoting the stemness of tumor cells 2025 ·Human Cell ·Xiaoyu Zhu, (unknown), Hui Qu, (unknown), (unknown), (unknown)	0
2	TJ0113-induced mitophagy in acute liver failure detected by Raman microspectroscopy 2025 ·Redox Biology ·(unknown), (unknown), Xufeng Cen, (unknown), Si‐Jia Chen, Dong Liu, Hui Qu, Jiansheng Zhu, Sailing He	1
3	TJ0113 attenuates fibrosis in metabolic dysfunction-associated steatohepatitis by inducing mitophagy 2025 ·International Immunopharmacology ·(unknown), (unknown), Xufeng Cen, Ting Ye, Hui Qu, Si‐Jia Chen, Dong Liu, Hongguang Xia, Chengfu Xu, Jiansheng Zhu	2
4	Chenodeoxycholic acid modulates cholestatic niche through FXR/Myc/P-selectin axis in liver endothelial cells 2025 ·Nature Communications ·(unknown), (unknown), (unknown), Yuanwen Zheng, (unknown), Jing Shen, Yong Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Xiaolong Tang, Cuijuan Zhang, Hui Qu, Ping Mi, Jin Chai, (unknown), Shiyang Li	7
5	The past, present, and future of ALK-targeted drug discovery 2025 ·European Journal of Medicinal Chemistry ·Hui Qu, Jingru Zhang, Xinxin Zhao, (unknown), Lian Duan, Lin Yuan	0
6	Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure 2025 ·Drug Design Development and Therapy ·(unknown), Hui Qu, (unknown), (unknown), Hui Shao, (unknown), Huazhong Chen, Tao‐Hsin Tung, Jiansheng Zhu	1
7	Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis 2024 ·Oncogene ·Xiaolong Tang, Lei Gao, (unknown), Zhenyu Hou, Yiwen Wang, (unknown), Hui Qu	13
8	Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer 2022 ·Cell Death and Disease ·Xiaolong Tang, (unknown), Guorui Sun, Qingsi He, Zhenyu Hou, (unknown), Peng Gao, Hui Qu	28
9	Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma 2022 ·Frontiers in Immunology ·Zheng Zhu, Guoyin Li, Zhenning Li, Yinghua Wu, Yan Yang, Mingyang Wang, Huihua Zhang, Hui Qu, Zewen Song, Yuanmin He	8
10	Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer 2020 ·Cell Death and Disease ·Xiaolong Tang, Guorui Sun, Qingsi He, Chao Wang, (unknown), Lei Gao, Jianhong Ye, (unknown), Hui Qu	29
11	Translation regulatory long non‑coding RNA 1 represents a potential prognostic biomarker for colorectal cancer 2020 ·Oncology Letters ·Weijia Wang, (unknown), Hui Qu, Qingsi He	8
12	Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation 2018 ·Gene ·Yuping Zhou, (unknown), Hui Qu, (unknown), Liyun Fu, Linwen Zhu, Guoliang Ye, Junming Guo	31
13	Knockdown of RAI14 suppresses the progression of gastric cancer 2018 ·OncoTargets and Therapy ·Cheng Chen, (unknown), Xin Zhang, Hui Qu, (unknown), (unknown), Wenbin Yu	20
14	The role of Golgi reassembly and stacking protein 65 phosphorylation in H2O2-induced cell death and Golgi morphological changes 2016 ·Medical Molecular Morphology ·(unknown), Weiwei Zhang, (unknown), Yang Chen, Hui Qu, Zhiping Hu	2
15	Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition 2016 ·Oncology Reports ·Hui Qu, Hong Yin, Su Yan, Min Tao, Yufeng Xie, Weichang Chen	13
16	CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer 2015 ·Clinical & Translational Oncology ·Xue Zhang, Bing Song, (unknown), Dong Sun, (unknown), Hui Qu	11
17	Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling 2012 ·Clinical Cancer Research ·Changgeng Qian, Cheng-Jung Lai, Rudi Bao, Da-Gong Wang, Jing Wang, Guang-Xin Xu, Ruzanna Atoyan, Hui Qu, Ling Yin, Maria Samson, Brian Zifcak, (unknown), Steven DellaRocca, Mylissa Borek, Hai-Xiao Zhai, Xiong Cai, Maurizio Voi	188
18	CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity 2010 ·Cancer Research ·Cheng-Jung Lai, Rudi Bao, Xu Tao, Jing Wang, Ruzanna Atoyan, Hui Qu, Da-Gong Wang, Ling Yin, Maria Samson, Jeffrey Forrester, Brian Zifcak, Guang-Xin Xu, Steven DellaRocca, Hai-Xiao Zhai, Xiong Cai, William E. Munger, Mitchell Keegan, Carmen V. Pepicelli, Changgeng Qian	182
19	CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy 2009 ·Clinical Cancer Research ·Rudi Bao, Cheng-Jung Lai, Hui Qu, Da-Gong Wang, Ling Yin, Brian Zifcak, Ruzanna Atoyan, Jing Wang, Maria Samson, Jeffrey Forrester, Steven DellaRocca, Guang-Xin Xu, Xu Tao, Hai-Xiao Zhai, Xiong Cai, Changgeng Qian	80
20	Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer 2009 ·Molecular Cancer Therapeutics ·Rudi Bao, Cheng-Jung Lai, Da-Gong Wang, Hui Qu, Ling Yin, Brian Zifcak, Xu Tao, Jing Wang, Ruzanna Atoyan, Maria Samson, Jeffrey Forrester, Guang-Xin Xu, Steven DellaRocca, Mylissa Borek, Hai-Xiao Zhai, Xiong Cai, Changgeng Qian	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact